NEW YORK (GenomeWeb News) – Hologic this week announced a handful of executive appointments and the impending retirement of its CFO.

The firm said that it has named Eric Compton to the newly-established position of chief operating officer. He will be responsible for overseeing all of the firm's commercial operations in the US, and its global research and development, manufacturing, and service operations. Compton most recently served as worldwide president of Johnson & Johnson's Ortho Clinical Diagnostics business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.